- Home
- PEPG vs TURN Comparison
PEPG vs TURN Comparison
Compare PEPG & TURN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- TURN
- Stock Information
- Founded
- PEPG 2018
- TURN 1981
- Country
- PEPG United States
- TURN United States
- Employees
- PEPG N/A
- TURN N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- TURN Finance/Investors Services
- Sector
- PEPG Health Care
- TURN Finance
- Exchange
- PEPG Nasdaq
- TURN Nasdaq
- Market Cap
- PEPG 45.9M
- TURN 49.6M
- IPO Year
- PEPG 2022
- TURN N/A
- Fundamental
- Price
- PEPG $2.56
- TURN $4.96
- Analyst Decision
- PEPG Buy
- TURN
- Analyst Count
- PEPG 4
- TURN 0
- Target Price
- PEPG $7.25
- TURN N/A
- AVG Volume (30 Days)
- PEPG 633.9K
- TURN 33.2K
- Earning Date
- PEPG 11-06-2025
- TURN 02-26-2018
- Dividend Yield
- PEPG N/A
- TURN N/A
- EPS Growth
- PEPG N/A
- TURN N/A
- EPS
- PEPG N/A
- TURN 0.29
- Revenue
- PEPG N/A
- TURN $488,011.00
- Revenue This Year
- PEPG N/A
- TURN N/A
- Revenue Next Year
- PEPG N/A
- TURN N/A
- P/E Ratio
- PEPG N/A
- TURN $17.34
- Revenue Growth
- PEPG N/A
- TURN 277.43
- 52 Week Low
- PEPG $0.88
- TURN $3.12
- 52 Week High
- PEPG $9.94
- TURN $5.01
- Technical
- Relative Strength Index (RSI)
- PEPG 74.19
- TURN 11.74
- Support Level
- PEPG $1.82
- TURN $4.51
- Resistance Level
- PEPG $2.24
- TURN $5.01
- Average True Range (ATR)
- PEPG 0.28
- TURN 0.11
- MACD
- PEPG 0.09
- TURN -0.46
- Stochastic Oscillator
- PEPG 97.64
- TURN 0.00
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.